MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acs.jproteome.5c00047

Медицинская библиотека · Journal of proteome research · 2025

Brain, CSF, and Blood Metabolomics Signature in the TgF344-AD Rat Model of Alzheimer's Disease.

Altine Samey Rayhanatou, Mavel Sylvie, Ceyzériat Kelly, Chalon Sylvie, Nadal-Desbarats Lydie, Bodard Sylvie, Lefevre Antoine, Busson Julie, Chicheri Gabrielle, Antier Daniel, Millet Philippe, Emond Patrick, Tournier Benjamin B, Foucault-Fruchard Laura

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder, affecting millions of elderly patients and representing a common cause of dementia worldwide. Among the molecular and cellular processes involved in AD pathogenesis, the extracellular aggregation of β-amyloid (Aβ) has been strongly linked to AD progression. As AD advances, the metabolic profiles of the brain and other organs undergo significant changes. Metabolomics serves as an invaluable tool for discovering biomarkers to enable early diagnosis of AD. Using liquid chromatography-mass spectrometry (LC-MS), we analyzed brain tissues (from the frontal cortex and hippocampus), cerebrospinal fluid, and plasma from TgF344-AD rats (n = 8 males) and wild-type rats (n = 8), aged 7 months, identifying 710 analytically robust metabolites across the four biological matrices. A similar methodology was applied to 12 rats aged 22 months. Our results highlighted that the metabolomic profiles and altered metabolic pathways varied between early and advanced stages in both central and peripheral matrices. At 7 months, the metabolic fingerprint showed alterations predominantly affecting amino acid and lipid metabolism, whereas by 22 months, it shifted to a distinct fingerprint impacting amino acid, lipid, and nucleotide metabolism. These findings provide insights that could support the development of diagnostic tools and targeted therapeutic strategies tailored to each stage of the disease.

Для цитирования: Altine Samey Rayhanatou, Mavel Sylvie, Ceyzériat Kelly, Chalon Sylvie, Nadal-Desbarats Lydie, Bodard Sylvie, Lefevre Antoine, Busson Julie, Chicheri Gabrielle, Antier Daniel, Millet Philippe, Emond Patrick, Tournier Benjamin B, Foucault-Fruchard Laura. Brain, CSF, and Blood Metabolomics Signature in the TgF344-AD Rat Model of Alzheimer's Disease.. Journal of proteome research. 2025. DOI: 10.1021/acs.jproteome.5c00047.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.